STRS Ohio’s Generation Bio GBIO Stock Holding History

STRS Ohio’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-310	Closed	-$88K	–	2305
2021 Q1	$88K	Hold	310	–	–	﹤0.01%	1965
2020 Q4	$87K	Hold	310	–	–	﹤0.01%	1914
2020 Q3	$95K	Buy	+310	New	+$74.1K	﹤0.01%	1854

Other funds holding GBIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

STRS Ohio's GBIO Position: Q2 2021 in Review

STRS Ohio sold out of Generation Bio (GBIO) in Q2 2021, closing a stake of 310 shares — an estimated $88K sold.

STRS Ohio first reported a position in GBIO in Q3 2020 and held it in 3 quarters. The position peaked at $95K in Q3 2020. 97 funds tracked by Wall St. Rank hold GBIO as of Q2 2021.

STRS Ohio reported no remaining Generation Bio position as of Q2 2021 after selling out during the quarter.
STRS Ohio sold 310 Generation Bio shares in Q2 2021, an estimated $88K.
STRS Ohio first reported a position in Generation Bio in Q3 2020 and held it in 3 quarters.
STRS Ohio's Generation Bio position peaked at $95K in Q3 2020.
97 funds tracked by Wall St. Rank held Generation Bio as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.